Form 4: Encompass Health Director Acquires Additional Shares Through Dividend Reinvestment

Terrance Williams, a director of Encompass Health Corp, acquired 24 shares of common stock through a dividend reinvestment program on October 15, 2024.

Summary

• On October 15, 2024, Terrance Williams, a director of Encompass Health Corp, acquired 24 shares of common stock.
• The acquisition was a result of dividend payments on outstanding restricted stock units (RSUs).
• Encompass Health paid a dividend of $0.17 per share, and the closing price on the dividend payment date was $96.33.
• Following the transaction, Williams directly owns 13,622 shares of Encompass Health common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transaction reflects a routine dividend reinvestment, indicating confidence in the company's dividend policy and stock performance.

Positives

• The director's acquisition of shares through dividend reinvestment demonstrates confidence in the company's performance.

Industry Context

This filing is a routine disclosure of a director's stock acquisition through a dividend reinvestment program, which is a common practice among publicly traded companies.

Comparison to Industry Standards

• Dividend reinvestment programs are a standard practice in many publicly traded companies, including those in the healthcare sector such as Universal Health Services and HCA Healthcare.
• Director ownership is also common, and the level of ownership is comparable to other directors in similar-sized healthcare companies.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine acquisition of shares by a director.

Key Dates